Entera Bio
ENTX
ENTX
12 hedge funds and large institutions have $15.9M invested in Entera Bio in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
40% less capital invested
Capital invested by funds: $26.7M → $15.9M (-$10.8M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
12
Holding in Top 10
1
Calls
$752K
Puts
$166K
Top Buyers
| 1 | +$113K | |
| 2 | +$33K | |
| 3 | +$22.3K | |
| 4 |
Morgan Stanley
New York
|
+$1.68K |
Top Sellers
| 1 | -$89K | |
| 2 | -$54K | |
| 3 | -$40.6K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$34.7K |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$11.9K |